Teruya-Feldstein J - Search Results

1

Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Ma L, et al. Cancer Res. 2007 Aug 1;67(15):7106-12. doi: 10.1158/0008-5472.CAN-06-4798. Cancer Res. 2007. PMID: 17671177

2

Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.

Ma L, Teruya-Feldstein J, Behrendt N, Chen Z, Noda T, Hino O, Cordon-Cardo C, Pandolfi PP. Ma L, et al. Genes Dev. 2005 Aug 1;19(15):1779-86. doi: 10.1101/gad.1314405. Epub 2005 Jul 18. Genes Dev. 2005. PMID: 16027168 Free PMC article.

3

PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.

Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, Cordon-Cardo C, Simon MC, Rafii S, Pandolfi PP. Bernardi R, et al. Nature. 2006 Aug 17;442(7104):779-85. doi: 10.1038/nature05029. Nature. 2006. PMID: 16915281

4

Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. Carracedo A, et al. J Clin Invest. 2008 Sep;118(9):3065-74. doi: 10.1172/JCI34739. J Clin Invest. 2008. PMID: 18725988 Free PMC article.

5

Pml represses tumour progression through inhibition of mTOR.

Bernardi R, Papa A, Egia A, Coltella N, Teruya-Feldstein J, Signoretti S, Pandolfi PP. Bernardi R, et al. EMBO Mol Med. 2011 May;3(5):249-57. doi: 10.1002/emmm.201100130. Epub 2011 Mar 8. EMBO Mol Med. 2011. PMID: 21387562 Free PMC article.

6

p63 expression profiles in human normal and tumor tissues.

Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. Di Como CJ, et al. Clin Cancer Res. 2002 Feb;8(2):494-501. Clin Cancer Res. 2002. PMID: 11839669

7

Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.

Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. Maeda T, et al. Nature. 2005 Jan 20;433(7023):278-85. doi: 10.1038/nature03203. Nature. 2005. PMID: 15662416 Free article.

8

A CK2-dependent mechanism for degradation of the PML tumor suppressor.

Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B, Teruya-Feldstein J, Tempst P, Pandolfi PP. Scaglioni PP, et al. Cell. 2006 Jul 28;126(2):269-83. doi: 10.1016/j.cell.2006.05.041. Cell. 2006. PMID: 16873060 Free article.

9

Ubiquitination regulates PTEN nuclear import and tumor suppression.

Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, Pandolfi PP. Trotman LC, et al. Cell. 2007 Jan 12;128(1):141-56. doi: 10.1016/j.cell.2006.11.040. Cell. 2007. PMID: 17218261 Free PMC article.

10

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.

Sportoletti P, Grisendi S, Majid SM, Cheng K, Clohessy JG, Viale A, Teruya-Feldstein J, Pandolfi PP. Sportoletti P, et al. Blood. 2008 Apr 1;111(7):3859-62. doi: 10.1182/blood-2007-06-098251. Epub 2008 Jan 22. Blood. 2008. PMID: 18212245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters